Emma James, PhD

Dr. Emma James is VP Clinical and Medical Affairs; Head of Medical OfficeVP Clinical and Medical Affairs; Head of Medical Office at Encoded Therapeutics, a biotech company developing innovative gene therapies for patients with central nervous system disorders. She obtained her PhD from the University of Oxford, after completing her research at its Nuffield Department of Medicine and Wellcome Trust Centre for Human Genetics.

Dr. James has focused the last 8 years on developing gene therapies for rare, pediatric and genetic disorders. In 2018, she was awarded Honorary Membership of the Faculty of Pharmaceutical Medicine of the United Kingdom’s Royal College of Physicians in recognition of her contributions to pharmaceutical medicine. In 2021, Emma was invited to join the Pediatric Gene Therapy and Medical Ethics (PGTME) Working Group, a multidisciplinary group with the mission to advance research, policy, and education regarding ethical issues surrounding clinical trials of gene therapy.